Gender | Age (years) | Hematologic malignancy (number of patients) | Conditioning regimen | Acute GVHD | Chronic GVHD | CD34 doseaper recipient kg (×106) |
---|---|---|---|---|---|---|
5 females | Average: 46 | Acute lymphoblastic leukemia: 1 | Myeloablative: 2 | Grade I: 1 | Limited: 3 | Average: 8.1 |
6 males | Median: 56 | Acute myelogenous leukemia: 3 | Nonmyeloablative: 1 | Grade II: 4 | None: 8 | Median: 9.0 |
Range: 23 to 60 | Hodgkin disease: 1 | Reduced intensity: 8 | Grade III: 2 | Range: 3.6 to 10.0 | ||
Myelodyplastic syndrome: 2 | None: 4 | |||||
Non-Hodgkin lymphoma: 3 | ||||||
Plasma cell leukemia: 1 |